Consolidated Statement Of Comprehensive Income

ONO PHARMACEUTICAL CO., LTD. - Filing #7602299

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
80,519,000,000 JPY
80,519,000,000 JPY
80,684,000,000 JPY
166,000,000 JPY
75,425,000,000 JPY
75,425,000,000 JPY
75,497,000,000 JPY
72,000,000 JPY
Other comprehensive income
Items that will not be reclassified to profit or loss
Remeasurements of defined benefit plans
199,000,000 JPY
2,370,000,000 JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income
-2,094,000,000 JPY
17,273,000,000 JPY
Total of items that will not be reclassified to profit or loss
-1,893,000,000 JPY
19,646,000,000 JPY
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
814,000,000 JPY
424,000,000 JPY
Total of items that may be reclassified to profit or loss
814,000,000 JPY
424,000,000 JPY
Other comprehensive income
-1,074,000,000 JPY
-1,074,000,000 JPY
-1,079,000,000 JPY
-4,000,000 JPY
20,064,000,000 JPY
20,070,000,000 JPY
6,000,000 JPY
20,064,000,000 JPY
Comprehensive income
JPY
79,444,000,000 JPY
JPY
-1,074,000,000 JPY
80,519,000,000 JPY
79,606,000,000 JPY
JPY
161,000,000 JPY
JPY
95,488,000,000 JPY
JPY
JPY
75,425,000,000 JPY
95,567,000,000 JPY
78,000,000 JPY
20,064,000,000 JPY
Comprehensive income attributable to
Owners of parent
79,444,000,000 JPY
95,488,000,000 JPY
Non-controlling interests
161,000,000 JPY
78,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.